Lactoferrin-induced myeloid-derived suppressor cell therapy attenuates pathologic inflammatory conditions in newborn mice.
Liu Y, Perego M, Xiao Q, He Y, Fu S, He J, Liu W, Li X, Tang Y, Li X, Yuan W, Zhou W, Wu F, Jia C, Cui Q, Worthen GS, Jensen EA, Gabrilovich DI, Zhou J.
Liu Y, et al. Among authors: zhou j, zhou w.
J Clin Invest. 2019 Oct 1;129(10):4261-4275. doi: 10.1172/JCI128164.
J Clin Invest. 2019.
PMID: 31483289
Free PMC article.